Early AD Patient
Care Pathway

The early Alzheimer’s disease (AD) patient care pathway is an evolving process that calls for new practical strategies for a successful AD care program implementation and sustainability as well as structured approach to patient care. To learn more, the following resources are available to view, download, or listen to. These materials are intended for healthcare professionals treating and/or seeking to start treating early AD patients

The early Alzheimer’s disease (AD) patient care pathway is an evolving process that calls for new practical strategies for a successful AD care program implementation and sustainability as well as structured approach to patient care. To learn more, the following resources are available to view, download, or listen to. These materials are intended for healthcare professionals treating and/or seeking to start treating early AD patients

    Sort By

    Resources

    Content Type


    Apply Clear

Unfortunately, there are no results for this topic. Please modify your search.

Click Here to Go back

{{ promo.Title.slice(0, 160) }} Tooltip

{{ promo.Title }}

Title of the activity : {{ promo.Title }}

Provider : {{ promo.Provider }}

Virtual Enduring : {{ promo.VirtualEnduring }}

{{ promo.Title.slice(0, 160) }}

{{ promo.Title}}

{{ truncateText(promo.Title, promo.Description, 160) }}

Tooltip

{{ promo.Title }}

{{ promo.Description }}

{{ promo.AssetTag }}

COMING SOON

{{ promo.CTAText }}
Load More

Clinical Trials

Notepad

Clinical Trials

Eisai has numerous drug candidates in clinical development and is actively recruiting for trials in neurology.

Explore Clinical Trials

Grants

Support

Grants

This website provides policies and procedures for the preparation and submission of requests for Medical Education Grants (ME) and Investigator-Initiated Studies (IIS).

Explore Eisai Grants Process